Incidence and Outcomes of Gastrointestinal Bleeding in Patients With Percutaneous Mechanical Circulatory Support Devices.

[1]  N. Kapur,et al.  The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety , 2020, F1000Research.

[2]  F. Biancari,et al.  Letter by Dell'Aquila et al Regarding Article, "Extracorporeal Membrane Oxygenation as a Bridge to Durable Mechanical Circulatory Support: an Analysis of the STS-INTERMACS Database". , 2020, Circulation. Heart failure.

[3]  T. Ando,et al.  Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  D. Burkhoff,et al.  Trends in the Incidence of In-Hospital Mortality, Cardiogenic Shock, and Utilization of Mechanical Circulatory Support Devices in Myocarditis (Analysis of National Inpatient Sample Data, 2005-2014). , 2019, Journal of cardiac failure.

[5]  L. Hajjar,et al.  Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art , 2019, Critical Care.

[6]  M. Pahuja,et al.  Rivaroxaban for Left Ventricular Thrombus. , 2018, American journal of therapeutics.

[7]  D. Mcareavey,et al.  Advanced Percutaneous Mechanical Circulatory Support Devices for Cardiogenic Shock , 2017, Critical care medicine.

[8]  Sunil V. Rao,et al.  Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock , 2017, Circulation. Cardiovascular interventions.

[9]  R. Singal,et al.  Temporary Mechanical Circulatory Support in Cardiac Critical Care: A State of the Art Review and Algorithm for Device Selection. , 2017, The Canadian journal of cardiology.

[10]  V. Kushnir,et al.  Gastrointestinal Bleeding Following LVAD Placement from Top to Bottom , 2016, Digestive Diseases and Sciences.

[11]  F. Tacke,et al.  Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxis. , 2016, World journal of critical care medicine.

[12]  D. Conwell,et al.  Left Ventricular Assist Devices Impact Hospital Resource Utilization Without Affecting Patient Mortality in Gastrointestinal Bleeding , 2016, Digestive Diseases and Sciences.

[13]  J. Aranda,et al.  Gastrointestinal Bleeding During the Index Hospitalization for Mechanical Circulatory Support Devices Implantation, a Nationwide Perspective , 2016, Digestive Diseases and Sciences.

[14]  G. Reeder,et al.  Venous Strangulation as an Unusual Cause of MitraClip System Delivery Failure. , 2015, JACC. Cardiovascular interventions.

[15]  J. Menaker,et al.  Epidemiology of gastrointestinal bleeding in adult patients on extracorporeal life support , 2015, Intensive Care Medicine.

[16]  A. Barkun,et al.  Stress-related mucosal disease in the critically ill patient , 2015, Nature Reviews Gastroenterology &Hepatology.

[17]  A. Guha,et al.  Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management. , 2015, Methodist DeBakey cardiovascular journal.

[18]  D. Yuh,et al.  National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. , 2014, Journal of the American College of Cardiology.

[19]  Robert J. Huang,et al.  GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. , 2014, Gastrointestinal endoscopy.

[20]  W. O’Neill,et al.  The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry , 2013, Journal of interventional cardiology.

[21]  A. Spotnitz,et al.  The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. , 2014, The Annals of thoracic surgery.

[22]  Sameer Islam,et al.  Left Ventricular Assist Devices and Gastrointestinal Bleeding: A Narrative Review of Case Reports and Case Series , 2013, Clinical cardiology.

[23]  K. Lamb,et al.  Successful management of bleeding complications in patients supported with extracorporeal membrane oxygenation with primary respiratory failure , 2013, Perfusion.

[24]  S. Cook,et al.  Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock: Results of the Impella–EUROSHOCK-Registry , 2013, Circulation. Heart failure.

[25]  R. Magorien,et al.  Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: Vascular complications and incidence of bleeding , 2012, Acute cardiac care.

[26]  G. Ewald,et al.  Evaluation of GI bleeding after implantation of left ventricular assist device. , 2012, Gastrointestinal endoscopy.

[27]  H. Hirose,et al.  Adult extracorporeal membrane oxygenation and gastrointestinal bleeding from small bowel arteriovenous malformations: a novel treatment using spiral enteroscopy. , 2012, The Journal of thoracic and cardiovascular surgery.

[28]  Priya Sharma,et al.  Incidence and management of gastrointestinal bleeding with continuous flow assist devices. , 2012, The Annals of thoracic surgery.

[29]  G. Rosenthal,et al.  Finding pure and simple truths with administrative data. , 2012, JAMA.

[30]  G. Fonarow,et al.  Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database. , 2011, American heart journal.

[31]  Andrew Boyle,et al.  Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. , 2009, The Journal of thoracic and cardiovascular surgery.

[32]  M. Cappell,et al.  Characterization of ischemic colitis associated with myocardial infarction: an analysis of 23 patients. , 2006, The American journal of medicine.